Pulling SEC filings + quote and writing the call…
Not at current levels — our verdict on Celcuity Inc. (CELC) is HOLD (conviction 3 of 5): fairly priced on the filings; own it, don't chase it.
Binary PI3K/mTOR bet on gedatolisib — VIKTORIA-1 cohort 1 readout in hand, well-funded into next catalyst, but pre-revenue and burning ~$153M/yr.
We re-rate when the company’s filings change, never the chart. Every change lands on the Flip Side and is scored on the live track record.
AI-generated analysis, produced by our proprietary engine from SEC filing data.
Investment recommendation produced by TENK/calls (tenkcalls.com), Luxembourg. Completed Jun 25, 2026, 8:47 AM ET. Ratings & methodology: definitions · All recommendations to date: track record · Conflicts: disclosures. Not investment advice.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.